StockNews.com Begins Coverage on Phibro Animal Health (NASDAQ:PAHC)

StockNews.com began coverage on shares of Phibro Animal Health (NASDAQ:PAHC – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the stock.

Separately, Morgan Stanley decreased their price target on shares of Phibro Animal Health from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Thursday, February 9th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and an average target price of $18.00.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $14.05 on Thursday. Phibro Animal Health has a 12-month low of $11.75 and a 12-month high of $20.54. The firm has a market capitalization of $569.03 million, a price-to-earnings ratio of 19.79, a price-to-earnings-growth ratio of 7.55 and a beta of 0.61. The company has a quick ratio of 1.77, a current ratio of 3.54 and a debt-to-equity ratio of 1.71. The firm has a fifty day moving average of $15.02 and a 200-day moving average of $14.56.

Hedge Funds Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Brandes Investment Partners LP boosted its stake in shares of Phibro Animal Health by 100.3% during the 1st quarter. Brandes Investment Partners LP now owns 1,280,299 shares of the company’s stock worth $19,614,000 after buying an additional 640,958 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Phibro Animal Health by 5.7% during the 1st quarter. BlackRock Inc. now owns 3,789,646 shares of the company’s stock worth $75,604,000 after buying an additional 203,652 shares during the last quarter. Pzena Investment Management LLC boosted its stake in shares of Phibro Animal Health by 10.0% during the 1st quarter. Pzena Investment Management LLC now owns 2,165,200 shares of the company’s stock worth $33,171,000 after buying an additional 195,964 shares during the last quarter. Morgan Stanley boosted its stake in shares of Phibro Animal Health by 64.5% during the 4th quarter. Morgan Stanley now owns 467,638 shares of the company’s stock worth $6,271,000 after buying an additional 183,420 shares during the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of Phibro Animal Health by 106.6% during the 4th quarter. AQR Capital Management LLC now owns 271,247 shares of the company’s stock worth $3,637,000 after buying an additional 139,958 shares during the last quarter. 49.21% of the stock is owned by institutional investors and hedge funds.

About Phibro Animal Health

(Get Rating)

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.